Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Barringtonia racemosa
Arbre tropical de zones humides utilisé en médecine traditionnelle malaise, indienne et pacifique pour la fièvre, l'asthme et les maladies de peau.
Barringtonia racemosa, a tropical wetland tree, is traditionally used in Malay, Indian, and Pacific medicine for fever, asthma, and skin diseases. Its bark and leaves contain saponins, lupeol, flavonoids, and phenolics, which underpin antipyretic, bronchodilatory, and antimicrobial activities. Despite limited clinical evidence (Level C), it shows potential for respiratory and dermatological conditions.
The antipyretic effect is attributed to flavonoids and phenolics inhibiting cyclooxygenase (COX) and prostaglandin synthesis. Bronchodilation may involve lupeol and saponins acting as beta-2 adrenergic receptor agonists or calcium channel blockers, reducing airway smooth muscle contraction. Antimicrobial activity is linked to saponins disrupting microbial cell membranes and flavonoids inhibiting bacterial DNA gyrase.
Arbre tropical de zones humides utilisé en médecine traditionnelle malaise, indienne et pacifique pour la fièvre, l'asthme et les maladies de peau.
Barringtonia racemosa, a tropical wetland tree, is traditionally used in Malay, Indian, and Pacific medicine for fever, asthma, and skin diseases. Its bark and leaves contain saponins, lupeol, flavonoids, and phenolics, which underpin antipyretic, bronchodilatory, and antimicrobial activities. Despite limited clinical evidence (Level C), it shows potential for respiratory and dermatological conditions.
The antipyretic effect is attributed to flavonoids and phenolics inhibiting cyclooxygenase (COX) and prostaglandin synthesis. Bronchodilation may involve lupeol and saponins acting as beta-2 adrenergic receptor agonists or calcium channel blockers, reducing airway smooth muscle contraction. Antimicrobial activity is linked to saponins disrupting microbial cell membranes and flavonoids inhibiting bacterial DNA gyrase.